"However, lets not throw the baby out with the bath water." Dr
Once-daily prandial lixisenatide versus once-daily rapid-acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin: analysis of data from five randomized, controlled trials
Yes, although rarely, Mounjaro can lead to pancreatitis, gallbladder problems, kidney problems or allergic reactions
Ipamorelin, known for its human growth hormone releasing properties, can complement Sermorelins ability to stimulate the production of growth hormone from the pituitary gland
This is the expected physiological response, as leptin production correlates with fat stores
Discussions of risk versus benefit may include considerations of patient characteristics, such as history of DR, poor glycemic control, markedly elevated hemoglobin A1c, duration of diabetes, and other medications, particularly insulin